Diabetes Research - Insulin, Type I, Type II, Diet, Treatment, Prevention

Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.


Diabetes Research Today

Home

View Latest Issue

Information About Diabetes

Books on Diabetes

Advertising in Research Today

View Other Research Today Publications



Volume 5 (2008), Issue 1 (January)

  1. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy.
    Am J Obstet Gynecol, 198(1): 130.e1-7. [Abstract] [Full-text]
  2. Perspectives on obesity, pregnancy and birth outcomes in the United States: the scope of the problem.
    Am J Obstet Gynecol, 198(1): 23-7. [Abstract] [Full-text]
  3. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.
    Gastroenterology, 134(1): 95-101. [Abstract] [Full-text]
  4. Characterization of a novel congenic strain of diabetic fatty (WBN/Kob-Lepr(fa)) rat.
    Biochem Biophys Res Commun, 366(2): 556-62. [Abstract] [Full-text]
  5. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.
    Circulation, 117(1): 52-60. [Abstract] [Full-text]
  6. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
    Circulation, 117(1): 43-51. [Abstract] [Full-text]
  7. Prolonged cerebellar ataxia: an unusual complication of hypoglycemia.
    J Gen Intern Med, 23(1): 103-5. [Abstract] [Full-text]
  8. Concentration of chemokines in peripheral blood in first trimester of diabetic pregnancy.
    Acta Obstet Gynecol Scand, 87(1): 14-9. [Abstract] [Full-text]
  9. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.
    J Neurochem, 104(2): 491-9. [Abstract] [Full-text]
  10. Diabetes-induced coronary vascular dysfunction involves increased arginase activity.
    Circ Res, 102(1): 95-102. [Abstract] [Full-text]
  11. Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial.
    Lancet, 371(9606): 41-8. [Abstract] [Full-text]
  12. Long-term results of nail brace application in diabetic patients with ingrown nails.
    Dermatol Surg, 34(1): 84-6; discussion 86-7. [Abstract] [Full-text]
  13. Autoantibodies in type 1 diabetes.
    Autoimmunity, 41(1): 11-8. [Abstract] [Full-text]
  14. Serum potassium changes with initiating low-carbohydrate compared to a low-fat weight loss diet in type 2 diabetes.
    South Med J, 101(1): 46-9. [Abstract] [Full-text]
  15. Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice.
    Biochem Biophys Res Commun, 366(3): 814-20. [Abstract] [Full-text]
  16. c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury.
    Biochem Biophys Res Commun, 366(3): 710-6. [Abstract] [Full-text]
  17. Aortic elastic properties are related to left ventricular diastolic function in patients with type 1 diabetes mellitus.
    Cardiology, 109(2): 99-104. [Abstract] [Full-text]
  18. Phimosis as a presenting feature of diabetes.
    BJU Int, 101(3): 338-40. [Abstract] [Full-text]
  19. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.
    BJU Int, 101(3): 313-8. [Abstract] [Full-text]
  20. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin.
    Clin Sci (Lond), 114(3): 251-6. [Abstract] [Full-text]
  21. The relationship of plasma glucose and glycosylated hemoglobin A1C levels among nondiabetic trauma patients.
    J Trauma, 64(1): 30-3; discussion 33-4. [Abstract] [Full-text]
  22. Prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein cholesterol less than 100 mg/dL in older patients with diabetes mellitus in an academic nursing home.
    J Am Med Dir Assoc, 9(1): 51-4. [Abstract] [Full-text]
  23. Insulin allergy: clinical manifestations and management strategies.
    Allergy, 63(2): 148-55. [Abstract] [Full-text]
  24. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice.
    Am J Health Syst Pharm, 65(2): 145-9. [Abstract] [Full-text]
  25. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
    Lancet, 371(9607): 117-25. [Abstract] [Full-text]
  26. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Clin Immunol, 126(2): 140-7. [Abstract] [Full-text]
  27. Quality of diabetes care in family medicine practices: influence of nurse-practitioners and physician's assistants.
    Ann Fam Med, 6(1): 14-22. [Abstract] [Full-text]
  28. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease.
    Arch Intern Med, 168(1): 55-62. [Abstract] [Full-text]
  29. Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes.
    Clin Sci (Lond), 114(4): 313-20. [Abstract] [Full-text]
  30. Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects.
    Clin Exp Pharmacol Physiol, 35(2): 187-91. [Abstract] [Full-text]
  31. Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta.
    Clin Exp Pharmacol Physiol, 35(2): 192-200. [Abstract] [Full-text]
  32. Interleukin-12 and tumour necrosis factor-alpha equilibrium is a prerequisite for clinical course free from late complications in children with type 1 diabetes mellitus.
    Scand J Immunol, 67(2): 204-8. [Abstract] [Full-text]
  33. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    J Am Coll Cardiol, 51(3): 264-70. [Abstract] [Full-text]
  34. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later.
    J Pediatr, 152(2): 201-6. [Abstract] [Full-text]
  35. Dental findings in diabetic adults.
    Caries Res, 42(1): 14-8. [Abstract] [Full-text]
  36. The parental monitoring of diabetes care scale: development, reliability and validity of a scale to evaluate parental supervision of adolescent illness management.
    J Adolesc Health, 42(2): 146-53. [Abstract] [Full-text]
  37. Integrating epidemiological data into a mechanistic model of type 2 diabetes: validating the prevalence of virtual patients.
    Ann Biomed Eng, 36(2): 321-34. [Abstract] [Full-text]
  38. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.
    JAMA, 299(3): 316-23. [Abstract] [Full-text]
  39. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions.
    Pain Pract, 8(1): 45-56. [Abstract] [Full-text]
  40. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.
    Am Heart J, 155(2): 215-23. [Abstract] [Full-text]
  41. Increased arterial stiffness in normoglycemic normotensive offspring of type 2 diabetic parents.
    Hypertension, 51(2): 182-7. [Abstract] [Full-text]
  42. Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine.
    Hypertension, 51(2): 528-33. [Abstract] [Full-text]
  43. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes.
    Hypertension, 51(2): 534-9. [Abstract] [Full-text]
  44. Slow-wave sleep and the risk of type 2 diabetes in humans.
    Proc Natl Acad Sci U S A, 105(3): 1044-9. [Abstract] [Full-text]
  45. Viva la Vida: helping Latino Medicare beneficiaries with diabetes live their lives to the fullest.
    Am J Public Health, 98(2): 205-8. [Abstract] [Full-text]
  46. Self-monitoring of blood glucose before and after Medicare expansion among Medicare beneficiaries with diabetes who do not use insulin.
    Am J Public Health, 98(2): 358-64. [Abstract] [Full-text]
  47. Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus.
    Hypertension, 51(2): 440-5. [Abstract] [Full-text]
  48. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
    Arterioscler Thromb Vasc Biol, 28(2): 341-7. [Abstract] [Full-text]
  49. Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes study.
    Am J Public Health, 98(2): 365-70. [Abstract] [Full-text]
  50. Investigation of the mechanisms involved in the high-dose and long-term acetyl salicylic acid therapy of type I diabetic rats.
    J Pharmacol Exp Ther, 324(2): 850-7. [Abstract] [Full-text]
  51. Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release.
    J Pharmacol Exp Ther, 324(2): 658-63. [Abstract] [Full-text]
  52. Clinical trials with thiazolidinediones in subjects with Type 2 diabetes--is pioglitazone any different from rosiglitazone?
    Expert Opin Pharmacother, 9(3): 405-20. [Abstract] [Full-text]
  53. Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes.
    Expert Opin Pharmacother, 9(3): 343-9. [Abstract] [Full-text]
  54. The growing burden of diabetes mellitus in the US elderly population.
    Arch Intern Med, 168(2): 192-9; discussion 199. [Abstract] [Full-text]
  55. Clinic-based support to help overweight patients with type 2 diabetes increase physical activity and lose weight.
    Arch Intern Med, 168(2): 141-6. [Abstract] [Full-text]
  56. A new 'crowded uterine horn' mouse model for examining the relationship between foetal growth and adult obesity.
    Basic Clin Pharmacol Toxicol, 102(2): 162-7. [Abstract] [Full-text]
  57. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.
    Br J Ophthalmol, 92(2): 213-6. [Abstract] [Full-text]
  58. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects.
    Am J Obstet Gynecol, 198(2): 186.e1-7. [Abstract] [Full-text]
  59. Disorders of water and salt metabolism associated with pituitary disease.
    Endocrinol Metab Clin North Am, 37(1): 213-34, x. [Abstract] [Full-text]
  60. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition.
    Eur J Endocrinol, 158(2): 173-8. [Abstract] [Full-text]
  61. Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training.
    Eur J Endocrinol, 158(2): 163-72. [Abstract] [Full-text]
  62. Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients.
    Eur J Endocrinol, 158(2): 153-61. [Abstract] [Full-text]
  63. Glucokinase activators in diabetes management.
    Expert Opin Investig Drugs, 17(2): 145-67. [Abstract] [Full-text]
  64. Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.
    Clin Pharmacol Ther, 83(2): 288-92. [Abstract] [Full-text]
  65. Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography.
    Acta Ophthalmol Scand, 86(1): 34-9. [Abstract] [Full-text]
  66. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
    Acta Ophthalmol Scand, 86(1): 105-10. [Abstract] [Full-text]
  67. Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.
    Clin Exp Immunol, 151(3): 467-75. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Diabetes Research Today. All Rights Reserved.



Diabetes Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)



Diabetes Books

American Diabetes Association Complete Guide to Diabetes

American Diabetes Association Complete Guide to Diabetes